Multisystem inflammatory syndrome and autoimmune diseases following COVID-19: molecular mechanisms and therapeutic opportunities

P Hosseini, MS Fallahi, G Erabi, M Pakdin… - Frontiers in molecular …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2), has led to huge concern worldwide. Some SARS-CoV-2 …

The impact of Parkinson's disease on manifestations and outcomes of Covid‐19 patients: a systematic review and meta‐analysis

AE El‐Qushayri, S Ghozy, A Reda… - Reviews in medical …, 2022 - Wiley Online Library
Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid‐19)
had a decline in motor functions; nevertheless, there is limited evidence on whether PD …

Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection

AG Richter, AM Shields, A Karim, D Birch… - Clinical & …, 2021 - academic.oup.com
Summary Coronavirus 19 (COVID-19) has been associated with both transient and
persistent systemic symptoms that do not appear to be a direct consequence of viral …

Comparative features and outcomes of major neurological complications of COVID‐19

E Beghi, E Moro, EI Davidescu… - European journal of …, 2023 - Wiley Online Library
Background and purpose The aim of this study was to assess the neurological complications
of SARS‐CoV‐2 infection and compare phenotypes and outcomes in infected patients with …

[HTML][HTML] COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up

L Ahmad, P Businaro, S Regalbuto, M Gastaldi… - Medicine, 2022 - journals.lww.com
Abstract Single reports of Guillain-Barré syndrome (GBS) have been reported worldwide
during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. While …

Mapa de evidências sobre sequelas e reablitação da covid-19 pós-aguda: uma versão atualizada em julho de 2022

TLVDP Ostolin, RAR Miranda… - … de Salud Pública, 2023 - SciELO Public Health
Objetivo. Atualizar o mapa de evidências sobre os efeitos de intervenções para reabilitação
de covid-19 pós-aguda. Métodos. O escopo da busca foi definido conforme a população …

[HTML][HTML] Incidence of Guillain-Barré syndrome in the world between 1985 and 2020: A systematic review

VK Wachira, CM Farinasso, RB Silva, HM Peixoto… - Global …, 2023 - Elsevier
Abstract Introduction Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating
polyradiculoneuropathy that affects the peripheral nervous system. The study aimed to …

A 50-Year-Old Patient with Guillain–Barré Syndrome after COVID-19: A Case Report

T Chmiela, M Rzepka, E Krzystanek, A Gorzkowska - Medicina, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, causes acute respiratory
disease (coronavirus disease 2019; COVID-19). However, the involvement of other …

[HTML][HTML] SARS-Cov-2 damage on the nervous system and mental health

MS Boulkrane, V Ilina, R Melchakov… - Current …, 2022 - ncbi.nlm.nih.gov
Abstract The World Health Organization declared the pandemic situation caused by SARS-
CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed …

Current status of Guillain–Barré syndrome (GBS) in China: a 10-year comprehensive overview

Y Song, X Zheng, Y Fang, S Liu, K Liu… - Reviews in the …, 2023 - degruyter.com
Guillain–Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy; a disease
involving the peripheral nervous system which is the most common cause of acute flaccid …